Vitamin C use begins in Wuhan

Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia

2019 new coronavirus (2019-nCoV) infected pneumonia, namely severe acute respiratory infection (SARI) has caused global concern and emergency. There is a lack of effective targeted antiviral drugs, and symptomatic supportive treatment is still the current main treatment for SARI.

Vitamin C is significant to human body and plays a role in reducing inflammatory response and preventing common cold. In addition, a few studies have shown that vitamin C deficiency is related to the increased risk and severity of influenza infections.

We hypothesize that Vitamin C infusion can help improve the prognosis of patients with SARI. Therefore, it is necessary to study the clinical efficacy and safety of vitamin C for the clinical management of SARI through randomized controlled trials during the current epidemic of SARI.


Worldwide coronavirus death toll rises to 1,107

The Hubei health authority in China reported that 94 more people died of the coronavirus in Hubei province today, raising the death toll in the epicenter since the beginning of the outbreak to 1,068.

This brings the total number of deaths in mainland China to at least 1,105.

The global death toll is at least 1,107, with one death in Hong Kong and one death in the Philippines.

By the numbers: Hubei authorities confirmed an additional 1,638 cases of the virus in Hubei today, which brings the total number of cases in the epicenter of the outbreak to 33,366. The global number of confirmed coronavirus cases is now at least 44,138, with the vast majority of cases in mainland China.


Vitamin C use begins in Wuhan


ascorbate: Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
https://clinicaltrials.gov/ct2/show/NCT04264533


1107-44138: Worldwide coronavirus death toll rises to 1,107
https://edition.cnn.com/asia/live-news/coronavirus-outbreak-02-11-20-intl-hnk/index.html